Author Question: If a pharmaceutical company wished to design a drug to maintain low blood sugar (Read 547 times)

TI

  • Sr. Member
  • ****
  • Posts: 434
If a pharmaceutical company wished to design a drug to maintain low blood sugar levels, one approach might be to design a compound
A) that mimics epinephrine and can bind to the epinephrine receptor.
B) that stimulates cAMP production in liver cells.
C) to stimulate G protein activity in liver cells.
D) that increases phosphodiesterase activity.
E) that does any of the above.



coco

  • Hero Member
  • *****
  • Posts: 739
In class, we found it was D. Good luck with the rest.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question

TI

  • Sr. Member
  • ****
  • Posts: 434

 

Did you know?

The longest a person has survived after a heart transplant is 24 years.

Did you know?

Parkinson's disease is both chronic and progressive. This means that it persists over a long period of time and that its symptoms grow worse over time.

Did you know?

Computer programs are available that crosscheck a new drug's possible trade name with all other trade names currently available. These programs detect dangerous similarities between names and alert the manufacturer of the drug.

Did you know?

Oxytocin is recommended only for pregnancies that have a medical reason for inducing labor (such as eclampsia) and is not recommended for elective procedures or for making the birthing process more convenient.

Did you know?

About 3.2 billion people, nearly half the world population, are at risk for malaria. In 2015, there are about 214 million malaria cases and an estimated 438,000 malaria deaths.

For a complete list of videos, visit our video library